510(k) Report

510(k) · Cleared

Cleared

Vcare a

K121817510(k) TraditionalCleared Sep 17, 2013454-day reviewClass II21 CFR 878.4780

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

IVT Medical, Ltd. · OMP Negative Pressure Wound Therapy Powered Suction Pump

Cleared on Sep 17, 2013 as substantially equivalent to K062227 (Kci USA, Inc. (Kinetic Concepts, Inc.), 2006) after a 454-day review. Its family tree reaches back 7 generations to 1991.

Decided
Sep 17, 2013
Review
454 days
Class
Class II
Product code
OMP
Recalls
None
Predicates
1

Its longest line of descent runs back 7 generations to K914575 (1991). 18 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 7 generations backK914575 Sorbsan Topical Wound Dressing (Modified)Dow B. Hickam, Inc. · 1991
  2. 6 generations backK983210 Algisite MSmith & Nephew, Inc. · 1998
  3. 5 generations backK002896 Acticoat Foam Dressing, Algisite M Calcium Alginate DressingThe Westaim Corp. · 2001
  4. 4 generations backK024298 Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd. · 2003
  5. 3 generations backK050261 V.a.C. Granufoam Silver Protection DressingKinetic Concepts, Inc. · 2005
  6. 2 generations backK053627 Modification to: V.a.C. Granufoam Silver Protection DressingKci USA, Inc. · 2006
  7. 1 generation backK062227 V.a.C. Therapy SystemKci USA, Inc. (Kinetic Concepts, Inc.) · 2006 · Recalled
  8. This deviceK121817 Vcare aIVT Medical, Ltd. · 2013
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K914575Sorbsan Topical Wound Dressing (Modified)Dow B. Hickam, Inc.1991—
−6K983210Algisite MSmith & Nephew, Inc.1998—
−5K002896Acticoat Foam Dressing, Algisite M Calcium Alginate DressingThe Westaim Corp.2001—
−4K024298Antimicrobial Alginate DressingAdvanced Medical Solutions, Ltd.2003—
−3K050261V.a.C. Granufoam Silver Protection DressingKinetic Concepts, Inc.2005—
−2K053627Modification to: V.a.C. Granufoam Silver Protection DressingKci USA, Inc.2006—
−1K062227V.a.C. Therapy SystemKci USA, Inc. (Kinetic Concepts, Inc.)20062
0 (this device)K121817Vcare aIVT Medical, Ltd.2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199410
199510
199710
199910
200030
200210
200320
200510
FIG. 1 — Lineage of K121817, 1991–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMP device

  1. #1 K260646 Renasys Edge (66803126)score 15.3 · 14 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062227V.a.C. Therapy System
Summary page 1
…il: [email protected] Predicate Devices: The Vcare ao is substantially equivalent to the V.A.C. Therapy System, manufactured by Kinetic Concepts Inc., subject of k062227. Indications for Use: The Vcare a is intended for wound management via application of continual or intermittent negative pressur…
Kci USA, Inc. (Kinetic Concepts, Inc.)20062

Also cleared against K062227: 1 other device →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 22 years and passes through 8 companies; a new generation was cleared every 2.2 years on median.
  • 4 of the 18 ancestors have a recall of any class.
  • 1 other device also cites its predicate K062227.

How does its category compare?

All OMP devices

OMP Negative Pressure Wound Therapy Powered Suction Pump: FDA decisions, review times, recalls and adverse event reports over 20 years. 2013, this device’s year, is highlighted.

FDA decisions per year · OMP

5in 2025

2007: 62008: 82009: 82010: 62011: 62012: 112013: 112014: 102015: 202016: 192017: 112018: 132019: 152020: 62021: 92022: 102023: 82024: 92025: 52026 (partial year): 9
2007high 20 (2015) · low 5 (2025)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMP

127in 2025

2007: 113 days median2008: 98 days median2009: 87 days median2010: 97 days median2011: 123 days median2012: 292 days median2013: 84 days median2014: 179 days median2015: 189 days median2016: 146 days median2017: 137 days median2018: 214 days median2019: 249 days median2020: 179 days median2021: 238 days median2022: 229 days median2023: 291 days median2024: 181 days median2025: 127 days median2026 (partial year): 141 days median
2007high 292 (2012) · low 84 (2013)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · OMP

2in 2024

2009: 72010: 32012: 12013: 22014: 42015: 12016: 22019: 12024: 2
2007high 7 (2009) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · OMP

140in 2025

2007: 12008: 12009: 792010: 802011: 1302012: 972013: 1692014: 2292015: 3782016: 3982017: 3682018: 4222019: 9942020: 3,6642021: 1,4222022: 2582023: 1432024: 1352025: 140
2007high 3,664 (2020) · low 1 (2007)2025

MAUDE reports naming product code OMP, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007611301
200889801
2009887779
2010697380
201161230130
201211292197
201311842169
2014101794229
2015201891378
2016191462398
2017111370368
2018132140422
2019152491994
2020617903,664
2021923801,422
2022102290258
202382910143
202491812135
202551270140
202691410—

What is it indicated for?

The Vcare a is intended for wound management via application of continual or intermittent negative pressure to the wound for removal of fluids, including wound exudate, irrigation fluids, and infectious materials. It is indicated for management of chronic, acute, traumatic, sub-acute and dehisced wounds, partial-thickness bums, ulcers (such as diabetic or pressure), flaps and grafts. The Vcare a may promote healing by removal of excess exudates, irrigation fluids, and infectious material.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K121817: Vcare a.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121817

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026